Lycia raises $75M for food allergy and Graves’ diseasenews2026-06-26T14:13:11+00:00June 26th, 2026|Endpoints News|
EU regulators recommend revoking the marketing authorization for Amgen’s Tavneosnews2026-06-26T13:00:59+00:00June 26th, 2026|Endpoints News|
Tentative US–Iran deal partially re-opens Gulf shippingnews2026-06-26T12:10:00+00:00June 26th, 2026|Chemistry World|
How Epicrispr is using ‘digital twins’ to study a muscle disease therapynews2026-06-26T12:00:00+00:00June 26th, 2026|Endpoints News|
Michael Gilman retires as Arrakis CEO; Daniel Skovronsky joins Illumina’s board of directorsnews2026-06-26T11:00:47+00:00June 26th, 2026|Endpoints News|
ICIS TTF Early Day assessments: 26 June 2026news2026-06-26T09:26:00+00:00June 26th, 2026|Independent Commodity Intelligence Services (ICIS)|
